Koelmeyer RL - Search Results

1

Cardiovascular risk profiles in a lupus cohort: what do different calculators tell us?

Boulos D, Koelmeyer RL, Morand EF, Hoi AY. Boulos D, et al. Among authors: koelmeyer rl. Lupus Sci Med. 2017 Jul 28;4(1):e000212. doi: 10.1136/lupus-2017-000212. eCollection 2017. Lupus Sci Med. 2017. PMID: 29214035 Free PMC article.

2

Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus.

Mende R, Vincent FB, Kandane-Rathnayake R, Koelmeyer R, Lin E, Chang J, Hoi AY, Morand EF, Harris J, Lang T. Mende R, et al. Front Immunol. 2018 Jun 7;9:1250. doi: 10.3389/fimmu.2018.01250. eCollection 2018. Front Immunol. 2018. PMID: 29930551 Free PMC article.

3

The Rare Anaphylaxis-Associated FcγRIIa3 Exhibits Distinct Characteristics From the Canonical FcγRIIa1.

Anania JC, Trist HM, Palmer CS, Tan PS, Kouskousis BP, Chenoweth AM, Kent SJ, Mackay GA, Hoi A, Koelmeyer R, Slade C, Bryant VL, Hodgkin PD, Aui PM, van Zelm MC, Wines BD, Hogarth PM. Anania JC, et al. Front Immunol. 2018 Aug 20;9:1809. doi: 10.3389/fimmu.2018.01809. eCollection 2018. Front Immunol. 2018. PMID: 30177930 Free PMC article.

4

Analysis of serum B cell-activating factor from the tumor necrosis factor family (BAFF) and its soluble receptors in systemic lupus erythematosus.

Vincent FB, Kandane-Rathnayake R, Koelmeyer R, Hoi AY, Harris J, Mackay F, Morand EF. Vincent FB, et al. Clin Transl Immunology. 2019 Apr 21;8(4):e01047. doi: 10.1002/cti2.1047. eCollection 2019. Clin Transl Immunology. 2019. PMID: 31024730 Free PMC article.

5

Lupus Low Disease Activity State and Reduced Direct Health Care Costs in Patients With Systemic Lupus Erythematosus.

Yeo AL, Koelmeyer R, Kandane-Rathnayake R, Golder V, Hoi A, Huq M, Hammond E, Nab H, Nikpour M, Morand EF. Yeo AL, et al. Arthritis Care Res (Hoboken). 2020 Sep;72(9):1289-1295. doi: 10.1002/acr.24023. Arthritis Care Res (Hoboken). 2020. PMID: 31282076

6

Novel Methods of Incorporating Time in Longitudinal Multivariate Analysis Reveals Hidden Associations With Disease Activity in Systemic Lupus Erythematosus.

Nim HT, Connelly K, Vincent FB, Petitjean F, Hoi A, Koelmeyer R, Boyd SE, Morand EF. Nim HT, et al. Front Immunol. 2019 Jul 17;10:1649. doi: 10.3389/fimmu.2019.01649. eCollection 2019. Front Immunol. 2019. PMID: 31379847 Free PMC article.

7

High disease activity status suggests more severe disease and damage accrual in systemic lupus erythematosus.

Koelmeyer R, Nim HT, Nikpour M, Sun YB, Kao A, Guenther O, Morand E, Hoi A. Koelmeyer R, et al. Lupus Sci Med. 2020 May;7(1):e000372. doi: 10.1136/lupus-2019-000372. Lupus Sci Med. 2020. PMID: 32467293 Free PMC article.

8

Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus.

Vincent FB, Kandane-Rathnayake R, Koelmeyer R, Harris J, Hoi AY, Mackay F, Morand EF. Vincent FB, et al. Lupus Sci Med. 2020 Jun;7(1):e000375. doi: 10.1136/lupus-2019-000375. Lupus Sci Med. 2020. PMID: 32546562 Free PMC article.

9

Algorithm for calculating high disease activity in SLE.

Hoi A, Nim HT, Koelmeyer R, Sun Y, Kao A, Gunther O, Morand E. Hoi A, et al. Rheumatology (Oxford). 2021 Sep 1;60(9):4291-4297. doi: 10.1093/rheumatology/keab003. Rheumatology (Oxford). 2021. PMID: 33493337

10

Disease course following High Disease Activity Status revealed patterns in SLE.

Hoi A, Koelmeyer R, Bonin J, Sun Y, Kao A, Gunther O, Nim HT, Morand E. Hoi A, et al. Arthritis Res Ther. 2021 Jul 14;23(1):191. doi: 10.1186/s13075-021-02572-1. Arthritis Res Ther. 2021. PMID: 34261522 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters